Effectiveness of Predicted Low-Glucose Suspend Pump Technology in the Prevention of Hypoglycemia in People with Type 1 Diabetes Mellitus: Real-World Data Using DIA:CONN G8
- PMID: 39197835
- PMCID: PMC11788546
- DOI: 10.4093/dmj.2024.0039
Effectiveness of Predicted Low-Glucose Suspend Pump Technology in the Prevention of Hypoglycemia in People with Type 1 Diabetes Mellitus: Real-World Data Using DIA:CONN G8
Abstract
We evaluated the effectiveness of the predictive low-glucose suspend (PLGS) algorithm in the DIA:CONN G8. Forty people with type 1 diabetes mellitus (T1DM) who used a DIA:CONN G8 for at least 2 months with prior experience using pumps without and with PLGS were retrospectively analyzed. The objective was to assess the changes in time spent in hypoglycemia (percent of time below range [%TBR]) before and after using PLGS. The mean age, sensor glucose levels, glucose threshold for suspension, and suspension time were 31.1±22.8 years, 159.7±23.2 mg/dL, 81.1±9.1 mg/dL, and 111.9±79.8 min/day, respectively. Overnight %TBR <70 mg/dL was significantly reduced after using the algorithm (differences=0.3%, from 1.4%±1.5% to 1.1%±1.2%, P=0.045). The glycemia risk index (GRI) improved significantly by 4.2 (from 38.8±20.9 to 34.6±19.0, P=0.002). Using the PLGS did not result in a change in the hyperglycemia metric (all P>0.05). Our findings support the PLGS in DIA:CONN G8 as an effective algorithm to improve night-time hypoglycemia and GRI in people with T1DM.
Keywords: Blood glucose; Continuous glucose monitoring; Diabetes mellitus, type 1; Hypoglycemia; Insulin infusion systems.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.Diabetes Care. 2018 Oct;41(10):2155-2161. doi: 10.2337/dc18-0771. Epub 2018 Aug 8. Diabetes Care. 2018. PMID: 30089663 Clinical Trial.
-
Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.Diabetes Technol Ther. 2019 Sep;21(9):478-484. doi: 10.1089/dia.2019.0190. Epub 2019 Aug 1. Diabetes Technol Ther. 2019. PMID: 31329468 Free PMC article.
-
Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile.Diabetes Metab Syndr. 2021 May-Jun;15(3):695-701. doi: 10.1016/j.dsx.2021.03.017. Epub 2021 Mar 23. Diabetes Metab Syndr. 2021. PMID: 33813244 Clinical Trial.
-
The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.Pediatr Diabetes. 2020 Nov;21(7):1256-1267. doi: 10.1111/pedi.13088. Epub 2020 Sep 14. Pediatr Diabetes. 2020. PMID: 32738022
-
A Review of Predictive Low Glucose Suspend and Its Effectiveness in Preventing Nocturnal Hypoglycemia.Diabetes Technol Ther. 2019 Oct;21(10):602-609. doi: 10.1089/dia.2019.0119. Diabetes Technol Ther. 2019. PMID: 31335193
References
-
- The DCCT Research Group Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90:450–9. - PubMed
-
- Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care. 1997;20:22–5. - PubMed
-
- Abraham MB, de Bock M, Paramalingam N, O’Grady MJ, Ly TT, George C, et al. Prevention of insulin-induced hypoglycemia in type 1 diabetes with predictive low glucose management system. Diabetes Technol Ther. 2016;18:436–43. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical